Focusing and sustaining the antitumor CTL effector killer response by agonist anti-CD137 mAb.
Proc Natl Acad Sci U S A
; 112(24): 7551-6, 2015 Jun 16.
Article
in En
| MEDLINE
| ID: mdl-26034288
Key words
Full text:
1
Database:
MEDLINE
Main subject:
Melanoma, Experimental
/
T-Lymphocytes, Cytotoxic
/
Immunotherapy, Adoptive
/
Tumor Necrosis Factor Receptor Superfamily, Member 9
/
Antibodies, Monoclonal
Limits:
Animals
Language:
En
Year:
2015
Type:
Article